Deciphera Pharmaceuticals, Inc. announced that it has elected Frank S. Friedman to its Board of Directors. Mr. Friedman recently served as the global Chief Operating Officer of Deloitte Touche Tohmatsu Limited (Deloitte). Deciphera also announced that Michael Ross, Ph.D., will be stepping down from its Board of Directors. Mr. Friedman currently serves as Chief Executive Officer at a privately-held finance company.